ARG2
Basic information
Region (hg38): 14:67619920-67651708
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 29 | 3 | 1 |
Variants in ARG2
This is a list of pathogenic ClinVar variants found in the ARG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-67619982-C-A | not specified | Uncertain significance (Aug 14, 2023) | ||
14-67619987-A-T | Likely benign (Jun 04, 2018) | |||
14-67619995-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
14-67620085-G-A | Benign (Feb 01, 2018) | |||
14-67620953-G-C | not specified | Uncertain significance (Jan 03, 2024) | ||
14-67620954-C-G | not specified | Uncertain significance (Jun 05, 2024) | ||
14-67642210-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
14-67642305-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
14-67642316-A-T | not specified | Uncertain significance (Mar 14, 2023) | ||
14-67642317-G-C | not specified | Uncertain significance (May 04, 2022) | ||
14-67645647-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
14-67645675-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
14-67645740-A-C | not specified | Uncertain significance (Nov 17, 2023) | ||
14-67645767-C-A | not specified | Uncertain significance (Jul 05, 2022) | ||
14-67645788-G-C | not specified | Uncertain significance (Apr 03, 2023) | ||
14-67646644-G-A | not specified | Uncertain significance (Aug 10, 2023) | ||
14-67646649-A-G | Likely benign (Jul 09, 2018) | |||
14-67646662-T-C | not specified | Uncertain significance (Sep 20, 2023) | ||
14-67646681-G-A | not specified | Uncertain significance (Jul 28, 2021) | ||
14-67646692-G-T | not specified | Uncertain significance (Aug 21, 2023) | ||
14-67646976-C-G | not specified | Uncertain significance (May 01, 2022) | ||
14-67646979-G-T | not specified | Uncertain significance (Oct 02, 2023) | ||
14-67648051-C-A | not specified | Uncertain significance (Jan 10, 2022) | ||
14-67650779-G-A | Benign/Likely benign (Oct 01, 2022) | |||
14-67650811-T-C | not specified | Uncertain significance (May 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARG2 | protein_coding | protein_coding | ENST00000261783 | 8 | 31923 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000182 | 0.976 | 125658 | 0 | 90 | 125748 | 0.000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.344 | 176 | 189 | 0.930 | 0.00000918 | 2270 |
Missense in Polyphen | 59 | 72.207 | 0.8171 | 842 | ||
Synonymous | 0.153 | 69 | 70.6 | 0.977 | 0.00000337 | 739 |
Loss of Function | 2.01 | 9 | 18.3 | 0.492 | 0.00000109 | 202 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00101 | 0.000999 |
Ashkenazi Jewish | 0.000695 | 0.000695 |
East Asian | 0.00174 | 0.00174 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000160 | 0.000158 |
Middle Eastern | 0.00174 | 0.00174 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the regulation of extra-urea cycle arginine metabolism and also in down-regulation of nitric oxide synthesis. Extrahepatic arginase functions to regulate L-arginine bioavailability to nitric oxid synthase (NOS). Arginine metabolism is a critical regulator of innate and adaptive immune responses. Seems to be involved in negative regulation of the survival capacity of activated CD4(+) and CD8(+) T cells (PubMed:27745970). May suppress inflammation-related signaling in asthmatic airway epithelium (PubMed:27214549). May contribute to the immune evasion of H.pylori by restricting M1 macrophage activation and polyamine metabolism (By similarity). In fetal dendritic cells may play a role in promoting immune suppression and T cell TNF-alpha production during gestation (PubMed:28614294). Regulates RPS6KB1 signaling, which promotes endothelial cell senescence and inflammation and implicates NOS3/eNOS dysfunction (PubMed:22928666). Can inhibit endothelial autophagy independently of its enzymatic activity implicating mTORC2 signaling (PubMed:25484082). Involved in vascular smooth muscle cell senescence and apoptosis independently of its enzymatic activity (PubMed:23832324). Since NOS is found in the penile corpus cavernosum smooth muscle, the clitoral corpus cavernosum and the vagina, arginase-2 plays a role in both male and female sexual arousal (PubMed:12859189). {ECO:0000250|UniProtKB:O08691, ECO:0000269|PubMed:12859189, ECO:0000269|PubMed:22928666, ECO:0000269|PubMed:23832324, ECO:0000269|PubMed:25484082, ECO:0000269|PubMed:27214549, ECO:0000269|PubMed:27745970}.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Arginine biosynthesis - Homo sapiens (human);Amino Acid metabolism;Urea cycle and metabolism of amino groups;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism;urea cycle;Arginine Proline metabolism;Urea cycle
(Consensus)
Recessive Scores
- pRec
- 0.487
Intolerance Scores
- loftool
- 0.378
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.22
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- Y
- hipred_score
- 0.570
- ghis
- 0.509
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arg2
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- urea cycle;ureteric bud development;adaptive immune response;negative regulation of type 2 immune response;nitric oxide biosynthetic process;striated muscle contraction;arginine catabolic process to ornithine;negative regulation of tumor necrosis factor production;innate immune response;regulation of interleukin-1 beta secretion;negative regulation of macrophage inflammatory protein 1 alpha production;negative regulation of chemokine (C-C motif) ligand 4 production;negative regulation of chemokine (C-C motif) ligand 5 production;negative regulation of defense response to bacterium;regulation of reactive oxygen species biosynthetic process;negative regulation of tumor necrosis factor secretion;negative regulation of interleukin-17 secretion;negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process;negative regulation of CD4-positive, alpha-beta T cell proliferation;negative regulation of interleukin-13 secretion;positive regulation of cellular senescence
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix
- Molecular function
- arginase activity;manganese ion binding